3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Sarcoma, Alveolar Soft Part
1
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
1
Muscle-invasive Bladder Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
pembrolizumab
25
Cisplatin
9
Paclitaxel
6
Fluorouracil
5
Carboplatin
4
Saline Solution
3
Capecitabine
3
Bevacizumab
3
Oxaliplatin
2
Gemcitabine
2
Docetaxel
2
Cetuximab
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
lenvatinib
1
Trastuzumab
1
S 1 (combination)
1
Irinotecan
1
IFL protocol
1
Glucose
1
Doxorubicin
1
Brentuximab Vedotin
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
atezolizumab
×
Clear all
No trials found.